Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/196949
COMPARTIR / EXPORTAR:
SHARE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Therapeutic potential of allogeneic mesenchymal stromal cells transplantation for lupus nephritis |
Autor: | Barbado, J.; Tabera Bartolomé, Soraya; Sánchez, Ana; García-Sancho, Javier CSIC ORCID | Fecha de publicación: | 2018 | Editor: | Sage Publications | Citación: | Lupus 27(13): 2161-2165 (2018) | Resumen: | Animal and human studies have suggested the potential of mesenchymal stromal cells (MSCs) to treat systemic lupus erythematosus (SLE). Here, we present the results of compassionate MSC treatments for three SLE patients to provide the proof of concept for a randomized and controlled clinical trial. Three patients of different ethnicities who suffer from chronic SLE, and who presented with class IV active proliferative nephritis confirmed by biopsy, were treated with allogeneic MSCs from healthy donors. Ninety million cells were infused intravenously into each patient during high and very high activity disease flare-ups and follow-up was continued for 9 months. Multi-organic affectation was quantified by the SLE disease activity index (SLEDAI), and indicators of lupus nephritis activity, such as proteinuria, as well as lymphocyte and monocyte antigens and anti-HLA antibodies were measured at 1, 3, 6, and 9 months after treatment. Proteinuria levels improved dramatically during the 1st month after treatment and the ameliorations were sustained throughout the follow-up period. SLEDAI scores revealed early, durable, and substantial remissions that were complete for two patients and partial for the third patient and that permitted medication doses to be reduced 50-90%. These favourable outcomes support completion of the randomized and controlled MSC trial for SLE. | Versión del editor: | https://doi.org/10.1177/0961203318804922 | URI: | http://hdl.handle.net/10261/196949 | ISSN: | 0961-2033 | E-ISSN: | 1477-0962 | ISMN: | 10.1177/0961203318804922 |
Aparece en las colecciones: | (IBGM) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 59,24 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
30
checked on 16-mar-2024
SCOPUSTM
Citations
46
checked on 20-abr-2024
WEB OF SCIENCETM
Citations
43
checked on 25-feb-2024
Page view(s)
200
checked on 19-abr-2024
Download(s)
29
checked on 19-abr-2024
Google ScholarTM
Check
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.